Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marit Westerterp

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Circulation Research|June 23, 2018
A <i>Pad</i> 4 Plaque ErosionOliver Soehnlein, Venetia Bazioti, Marit Westerterp
European Heart Journal|June 28, 2023
Statins for ACTA2 mutation-driven atherosclerosis?Hanrui Zhang, Benedek Halmos, Marit Westerterp
Current Atherosclerosis Reports|July 3, 2023
T-cell Cholesterol Accumulation, Aging, and AtherosclerosisVenetia Bazioti, Benedek Halmos, Marit Westerterp
Circulation Research|June 25, 2016
High-Density Lipoproteins, Endothelial Function, and Mendelian RandomizationMarit Westerterp, Nan Wang, Alan R Tall
Journal of Cardiovascular Pharmacology|March 31, 2010
Cholesteryl ester transfer protein inhibition: a dysfunctional endotheliumMarit Westerterp, Joris Koetsveld, Alan R Tall
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2018
Adipocyte Membrane Cholesterol Regulates ObesityAnouk M la Rose, Venetia Bazioti, Marit Westerterp
Current Opinion in Lipidology|March 31, 2018
Myeloid cells regulate plasma LDL-cholesterol levelsVenetia Bazioti, Anouk M La Rose, Marit Westerterp
Current Opinion in Lipidology|April 22, 2026
A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?Katherine Muñoz Ayala, Eleonora A M Festen, Marit Westerterp
Diabetologia|August 15, 2014
Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese miceHongfeng Jiang, Marit Westerterp, Chunjiong Wang, et al.
Critical Reviews in Biochemistry and Molecular Biology|June 29, 2021
Cholesterol efflux pathways, inflammation, and atherosclerosisAnouk G Groenen, Benedek Halmos, Alan R Tall, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Circulation Research|June 23, 2018
A <i>Pad</i> 4 Plaque ErosionOliver Soehnlein, Venetia Bazioti, Marit Westerterp
European Heart Journal|June 28, 2023
Statins for ACTA2 mutation-driven atherosclerosis?Hanrui Zhang, Benedek Halmos, Marit Westerterp
Current Atherosclerosis Reports|July 3, 2023
T-cell Cholesterol Accumulation, Aging, and AtherosclerosisVenetia Bazioti, Benedek Halmos, Marit Westerterp
Circulation Research|June 25, 2016
High-Density Lipoproteins, Endothelial Function, and Mendelian RandomizationMarit Westerterp, Nan Wang, Alan R Tall
Journal of Cardiovascular Pharmacology|March 31, 2010
Cholesteryl ester transfer protein inhibition: a dysfunctional endotheliumMarit Westerterp, Joris Koetsveld, Alan R Tall
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2018
Adipocyte Membrane Cholesterol Regulates ObesityAnouk M la Rose, Venetia Bazioti, Marit Westerterp
Current Opinion in Lipidology|March 31, 2018
Myeloid cells regulate plasma LDL-cholesterol levelsVenetia Bazioti, Anouk M La Rose, Marit Westerterp
Current Opinion in Lipidology|April 22, 2026
A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?Katherine Muñoz Ayala, Eleonora A M Festen, Marit Westerterp
Diabetologia|August 15, 2014
Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese miceHongfeng Jiang, Marit Westerterp, Chunjiong Wang, et al.
Critical Reviews in Biochemistry and Molecular Biology|June 29, 2021
Cholesterol efflux pathways, inflammation, and atherosclerosisAnouk G Groenen, Benedek Halmos, Alan R Tall, et al.
Pageof 11